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Dear Editor, 
We refer to a paper recently published in the Journal of travel Medicine and Infectious 
Disease where clinicians have been shown to have in have many questions related to 
travellers to multiple destinations, going for prolonged duration of travel, with chronic 
medical conditions, and potential drug interactions.[1] This study highlighted the inadequacy 
of available information sources to resolve the wide range of different medical issues for 
travellers. In addition, the study also highlighted the significance of collaboration in travel 
health. 
A recent Home Medicines Review (HMR) highlighted the significance of collaborative 
interventions between pharmacists and medical practitioners for travellers with multiple 
medical conditions. A 70 year old man with a recent history of shortness of breath and 
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medications management was referred to a pharmacist for Home Medicines Review (HMR). 
The patient was also being managed for chronic cardiopulmonary disease and a degenerative 
musculoskeletal disorder and was using multiple medications (Table 1). 
Table 1 Patient’s regular medications  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apart from Prostate Specific Antigen test that was elevated for his age, chronic disease 
indicators including blood pressure, cholesterol and renal function were within normal 
ranges. The patient’s sexual history included multiple casual sexual partners. Tests for HIV 
and hepatitis C were negative. The patient had no known allergies and obtained his 
medications from a regular pharmacy while others were obtained overseas.  
At the medication review a, the patient disclosed to the pharmacist he did not have a regular 
GP and was preparing for a three month overseas to trip to Vietnam to visit friends. In less 
than a few weeks, the patient was to embark on a 6 hour flight from Darwin to Hanoi. As 
Medication Dose  
Rosuvastatin 10mg tablet 1 daily 
Metoprolol XL 23.75mg 1 daily 
Apirin 100mg 1 daily 
Fruseminde 20 mg tablet 
 
1 daily 
Diogoxin 250mcg tablet ½ daily 
Clopidogrel 75 mg tablet 1 daily 
Irbesartan 150 mg tablet 1 daily 
Morphine 100 mg CR 1 twice daily 
Esomeprazole 20mg tablet 1 daily 
Tiotropium 18mcg capsule I capsule inhaled daily 
Salmetarol/fluticasone250mcg/50 mcg 
accuhaler 
1 twice a day 
Testosterone 205mg injection 1 injection every 3 weeks 
 
Other medications sourced overseas 
Medication Dose 
Glucosamine 1000mg tablet 1 daily 
Fish oil 1000 capsule 1 daily 
Zinc 100mg 1 daily 
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travel was a serendipitous finding, it became apparent that the patient had not discussed his 
travel plans with a doctor and did not have sufficient medication to last for the duration of his 
travel. Noting the patients’ medical history and the potential health risks to disease 
exacerbation and thrombosis and medications misadventure during travel, the doctor 
requesting HMR report was informed and the patient referred back to the doctor for pre-travel 
health assessment and prescriptions orders to cover the duration of travel. Two weeks before 
date of departure, the patient presented at the pharmacy with prescription orders for influenza 
and pneumococcal vaccines. Medications to cover his duration overseas were also dispensed.  
Pharmacists routinely interact with patients and take medication and disease histories. 
However, there is paucity of research identifying pharmacists’ direct involvement in 
traveller’s care to improve outcomes. Pharmacists can assist with screening for routine 
vaccine needs based on patient’s diagnosis and medications prescribed. To optimise drug 
therapy, pharmacists in a collaborative protocol with medical practitioners have the 
opportunity to monitor adverse drug reactions for favourable treatment outcomes amongst 
travellers with underlying medical conditions. The case in this letter illustrates opportunities 
for pharmacists to identify travel health needs for individuals with chronic medical conditions 
prior to travel and collaborate with doctors to address these needs [2] The absence of research 
data on medications management including drug therapy and monitoring issues amongst 
travellers means that the effectiveness and quality of care for travellers with medical 
conditions remains unknown.  
For travellers with medical conditions, and taking multiple medications and supplements, the 
increased risk of drug-drug interactions and side effects highlights the need for checking with 
a pharmacist prior to travel. Underreported is the potential problem of concomitant 
medications use in travellers.[3] More work, particularly travel health research on 
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pharmacists’ expertise on drug interactions and role on collaborative care of travellers with 
chronic medical conditions is needed.[4]  
 
Pharmacists provide opportunity to access a qualified health professional for travel health 
promotion, education and preventative services. Promotion services include travel health 
messages in pharmacy mail outs and billings while preventative services may include 
referring patients to medical practitioners for routine immunisation updates and prophylactic 
medications. 
In conclusion, our experience is that travellers are in need of education about health risks 
during travel. Pharmacists operate from a wide range of settings-hospitals, community 
pharmacies retirement villages. The wide network of pharmacists’ work settings provides 
easily accessible information source for questions about drug interactions other drug-related 
information needs for travellers.  
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